Clinical Trial Update: Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus [Phase 2]

View source ↗

Summary

A Phase 2 study comparing single-dose versus repeat-dose regimens of AM-101 for acute inner ear tinnitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• AM 101

Snippet

Sponsor: Auris Medical, Inc. | Conditions: Tinnitus | Phase 2 | Status: COMPLETED